Your browser doesn't support javascript.
loading
Study of CJ016 in treatment of lung cancer / 中国药理学通报
Chinese Pharmacological Bulletin ; (12): 384-388, 2017.
Article en Zh | WPRIM | ID: wpr-510705
Biblioteca responsable: WPRO
ABSTRACT
Aim Tostudythetherapeuticeffectof CJ016 on human lung cancer model and the mecha-nism.Methods Anexperimentalhumanlungadeno-carcinoma model of A549 was set up to investigate the anti-tumor effect of CJ016,while the effect of angio-genesis and apoptosis in tumor were detected.Results In vitro,the cell proliferation was inhibited signifi-cantly by CJ016,and the value of IC50 was 34. 22 nmol ·L-1 .In vivo,the tumor inhibition rate and T/C%value were 70. 08%and 27. 75%,respectively,at the dose of 20 mg·kg-1 .Meanwhile,CJ016 could reduce the expression of CD31 and promote the apoptosis of tumorcells.Conclusion CJ016caninhibitthegrowth of A549 cells,and the possible mechanism may be re-lated to the reduction of angiogenesis and inducing tumor cell apoptosis.
Palabras clave
Texto completo: 1 Base de datos: WPRIM Idioma: Zh Revista: Chinese Pharmacological Bulletin Año: 2017 Tipo del documento: Article
Texto completo: 1 Base de datos: WPRIM Idioma: Zh Revista: Chinese Pharmacological Bulletin Año: 2017 Tipo del documento: Article